Documents
The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries
22 de junio de 2020
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.
Related
UNAIDS urges that all essential HIV services must continue while U.S. pauses its funding for foreign aid
01 de febrero de 2025
UNAIDS welcomes the decision by the US Secretary of State to continue life-saving HIV treatment and convenes partners to assess and mitigate impacts on HIV services
29 de enero de 2025
Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2025
17 de diciembre de 2024
Take the rights path to end AIDS — World AIDS Day report 2024
26 de noviembre de 2024
Peru approves groundbreaking law to extend health coverage for migrants with HIV and TB
21 de octubre de 2024
UNAIDS welcomes the Spanish government’s announcement of a new € 1 million contribution to overcome the global AIDS pandemic
15 de octubre de 2024
2024 global AIDS report — The Urgency of Now: AIDS at a Crossroads
22 de julio de 2024
Youth Next Level: guidance to strengthen sustainable youth-led HIV responses
19 de julio de 2024